Takahashi Muneaki, Miyata Haruka, Kametani Fuyuki, Nonaka Takashi, Akiyama Haruhiko, Hisanaga Shin-ichi, Hasegawa Masato
Department of Dementia and Higher Brain Function, Tokyo Metropolitan Institute of Medical Science, Setagaya-ku, Tokyo, 156-8506, Japan.
Acta Neuropathol. 2015 Jun;129(6):895-907. doi: 10.1007/s00401-015-1415-2. Epub 2015 Apr 14.
Alzheimer's disease (AD) is characterized by extracellular amyloid β (Aβ) deposition and intracellular tau aggregation. Many studies have indicated some association between these processes, but it remains unknown how the two pathologies are linked. In this study, we investigated whether expression of amyloid precursor protein (APP) influences extracellular seed-dependent intracellular tau accumulation in cultured cells. Treatment of tau-expressing SH-SY5Y cells with Aβ fibrils did not induce intracellular tau aggregation. On the other hand, in cells expressing both tau and APP, treatment with tau fibrils or Sarkosyl-insoluble tau from AD brains induced intracellular tau aggregation. The seed-dependent intracellular tau aggregation was not induced by expression of APP lacking the extracellular domain. The amount of phosphorylated tau aggregates in cultured cells was dose dependently elevated in response to increased levels of APP on the cell membrane. Our results indicate that the extracellular region of APP is involved in uptake of tau fibrils into cells, raising the possibility that APP, but not Aβ, influences cell-to-cell spreading of tau pathologies in AD by serving as a receptor of abnormal tau aggregates.
阿尔茨海默病(AD)的特征是细胞外淀粉样β蛋白(Aβ)沉积和细胞内tau蛋白聚集。许多研究表明了这些过程之间的某种关联,但这两种病理状态如何联系尚不清楚。在本研究中,我们调查了淀粉样前体蛋白(APP)的表达是否影响培养细胞中细胞外种子依赖的细胞内tau蛋白积累。用Aβ纤维处理表达tau蛋白的SH-SY5Y细胞并未诱导细胞内tau蛋白聚集。另一方面,在同时表达tau蛋白和APP的细胞中,用tau纤维或来自AD脑的 Sarkosyl不溶性tau处理可诱导细胞内tau蛋白聚集。缺乏细胞外结构域的APP的表达未诱导种子依赖的细胞内tau蛋白聚集。培养细胞中磷酸化tau聚集体的量随着细胞膜上APP水平的增加而呈剂量依赖性升高。我们的结果表明,APP的细胞外区域参与了tau纤维进入细胞的过程,这增加了一种可能性,即APP而非Aβ通过作为异常tau聚集体的受体影响AD中tau病理的细胞间传播。